Zobrazeno 1 - 10
of 931
pro vyhledávání: '"Rohit, Loomba"'
Autor:
Min Kyu Kang, Jeong Eun Song, Rohit Loomba, Soo Young Park, Won Young Tak, Young Oh Kweon, Yu Rim Lee, Jung Gil Park
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract We aimed to compare the associations of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) with coronary artery calcification (CAC). Patients who simultaneously u
Externí odkaz:
https://doaj.org/article/445e73a56adb4188a3b3deca94c088c9
Autor:
Mohammad Honarvar, Julio Lobo, Caitlin Schneider, Samuel Klein, Gordon I. Smith, Rohit Loomba, Alnoor Ramji, Tarek Hassanein, Eric M. Yoshida, Emily Pang, Michael P. Curry, Nezam H. Afdhal
Publikováno v:
WFUMB Ultrasound Open, Vol 2, Iss 2, Pp 100061- (2024)
Introduction: As prevalence of patients with steatotic liver diseases increases throughout the world, it is necessary to have accurate and accessible methods to estimate liver fat content. Using quantitative ultrasound parameters, such as attenuation
Externí odkaz:
https://doaj.org/article/7de839a8c75b49dab257ace0a800fd48
Autor:
Jia Hong Koh, MBBS, Douglas Chee, MBBS, Cheng Han Ng, MBBS, Karn Wijarnpreecha, MD, Mark Muthiah, MBBS, Darren Jun Hao Tan, MBBS, Wen Hui Lim, MBBS, Rebecca Wenling Zeng, MBBS, Benjamin Koh, MBBS, Eunice Tan Xiang Xuan, MBBS, Glenn Bonney, MD, Shridhar Iyer, MBBS, Dan Yock Young, MBBS, Toru Nakamura, MD, PhD, Hirokazu Takahashi, MD, PhD, Mazen Noureddin, MD, Mohammad Shadab Siddiqui, MD, Tracey G. Simon, MD, Rohit Loomba, MD, Daniel Q. Huang, MBBS, FRCP (UK), MMed (Int Med)
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1642 (2024)
Background. The cause of liver disease is changing, but its impact on liver transplantation (LT) for hepatocellular carcinoma (HCC) in women and men is unclear. We performed a nationwide study to assess the prevalence and posttransplant survival outc
Externí odkaz:
https://doaj.org/article/a363be454f6a4d8a9a65c6f8bf0753cc
Autor:
Zobair M. Younossi, Saleh A. AlQahtani, Jesús Funuyet-Salas, Manuel Romero-Gómez, Yusuf Yilmaz, Caglayan Keklikkiran, Khalid Alswat, Ming-Lung Yu, Chun-Jen Liu, Jian-Gao Fan, Ming-Hua Zheng, Patrizia Burra, Sven M. Francque, Laurent Castera, Jörn M. Schattenberg, Philip N. Newsome, Alina M. Allen, Mohamed El-Kassas, Sombat Treeprasertsuk, Saeed Hameed, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Hirokazu Takahashi, Takumi Kawaguchi, Marlen I. Castellanos Fernández, Ajay Duseja, Marco Arrese, Mary Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Lynn Gerber, Brian Lam, Lisa Fornaresio, Fatema Nader, C. Wendy Spearman, Stuart K. Roberts, Wah-Kheong Chan, Marcelo Silva, Andrei Racila, Pegah Golabi, Prooksa Ananchuensook, Linda Henry, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101066- (2024)
Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality of life (HRQL) and potential
Externí odkaz:
https://doaj.org/article/89eb6d0343c440378b078cf55412cc72
Autor:
Haushabhau S. Pagire, Suvarna H. Pagire, Byung-kwan Jeong, Won-Il Choi, Chang Joo Oh, Chae Won Lim, Minhee Kim, Jihyeon Yoon, Seong Soon Kim, Myung Ae Bae, Jae-Han Jeon, Sungmin Song, Hee Jong Lee, Eun Young Lee, Peter C. Goughnour, Dooseop Kim, In-Kyu Lee, Rohit Loomba, Hail Kim, Jin Hee Ahn
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is currently the leading cause of chronic liver disease worldwide. Metabolic Dysfunction-Associated Steatohepatitis (MASH), an advanced form of MASLD, can progress to liver fib
Externí odkaz:
https://doaj.org/article/36eae50bb8a2427487532c83a1c7cd4e
Autor:
Quentin M. Anstee, Jeremy Magnanensi, Yacine Hajji, Alexandra Caron, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Margery A. Connelly, Rohit Loomba, Stephen A. Harrison, Vlad Ratziu, Arun J. Sanyal
Publikováno v:
JHEP Reports, Vol 6, Iss 4, Pp 101011- (2024)
Background & Aims: Robust performance of non-invasive tests (NITs) across ages is critical to assess liver disease among patients with metabolic dysfunction-associated liver disease (MASLD). We evaluated the impact of age on the performance of NIS2+
Externí odkaz:
https://doaj.org/article/e823e08beef848c0a1ad7f05022bf9e3
Autor:
Sami Qadri, Emilia Vartiainen, Mari Lahelma, Kimmo Porthan, An Tang, Ilkay S. Idilman, Jurgen H. Runge, Anne Juuti, Anne K. Penttilä, Juhani Dabek, Tiina E. Lehtimäki, Wenla Seppänen, Johanna Arola, Perttu Arkkila, Jaap Stoker, Musturay Karcaaltincaba, Michael Pavlides, Rohit Loomba, Claude B. Sirlin, Taru Tukiainen, Hannele Yki-Järvinen
Publikováno v:
JHEP Reports, Vol 6, Iss 1, Pp 100928- (2024)
Background & Aims: Pathologists quantify liver steatosis as the fraction of lipid droplet-containing hepatocytes out of all hepatocytes, whereas the magnetic resonance-determined proton density fat fraction (PDFF) reflects the tissue triacylglycerol
Externí odkaz:
https://doaj.org/article/a39650dc9d9c4a118292df1177d010ab
Autor:
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramon Bataller, Ulrich Beuers, Jerome Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela E. Castro Narro, Abhijit Chowdhury, Helena Cortez-Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El-Kassas, Samuel Klein, Wayne Eskridge, Jiangao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero-Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia C. Sookoian, C. Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai-Sun Wong, Stavra Xanthakos, Yusuf Yilmaz, Zobair Younossi, Ansley Hobbs, Marcela Villota-Rivas, Philip N. Newsome
Publikováno v:
Annals of Hepatology, Vol 29, Iss 1, Pp 101133- (2024)
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favor of a chan
Externí odkaz:
https://doaj.org/article/f02c612b79da4aaa8837228f72393227
Autor:
Christina Gu, Nicole Bernstein, Nikita Mittal, Soumya Kurnool, Hannah Schwartz, Rohit Loomba, Atul Malhotra
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2231 (2024)
Obesity and metabolic syndrome affect the majority of the US population. Patients with obesity are at increased risk of developing type 2 diabetes (T2DM), obstructive sleep apnea (OSA), and metabolic dysfunction-associated steatotic liver disease (MA
Externí odkaz:
https://doaj.org/article/281b2a0c61044da5a24a5b22b170df5b
Autor:
Melanie Zheng, Daniel Q. Huang, Chigoziri Konkwo, Saaket Agrawal, Amit V. Khera, Rohit Loomba, Sílvia Vilarinho, Veeral Ajmera
Publikováno v:
JHEP Reports, Vol 5, Iss 4, Pp 100692- (2023)
Background & Aims: Lean patients with non-alcoholic fatty liver disease (NAFLD) represent 10–20% of the affected population and may have heterogeneous drivers of disease. We have recently proposed the evaluation of patients with lean NAFLD without
Externí odkaz:
https://doaj.org/article/90cb6f50ff804c8ca57961c07a448e30